The Risk of Febrile Seizures following Influenza and 13-Valent Pneumococcal Conjugate Vaccines

Project Title	The Risk of Febrile Seizures following Influenza and 13-Valent Pneumococcal Conjugate Vaccines
Date	Saturday, February 1, 2020
Location	Vaccine. 2020 Feb 1. doi: 10.1016/j.vaccine.2020.01.046
Description	Evidence on the risk of febrile seizures after inactivated influenza vaccine (IIV) and 13-valent pneumococcal conjugate vaccine (PCV13) is mixed. In the FDA-sponsored Sentinel Initiative, we examined risk of febrile seizures after IIV and PCV13 in children 6-23 months of age during the 2013-14 and 2014-15 influenza seasons.
Corresponding Author	Meghan A. Baker, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA, Division of Infectious Diseases, Department of Medicine, Brigham and Women’s Hospital, Boston, MA, USA Email: meghan_baker@harvardpilgrim.org
Authors	Meghan A. Baker, Christopher Jankosky, Katherine Yih, Susan Gruber, Lingling Li, Noelle M. Cocoros, Hana Lipowicz, Claudia Coronel-Moreno, Sandra DeLuccia, Nancy D. Lin, Cheryl N. McMahill-Walraven, David Menschik, Mano S. Selvan, Nandini Selvam, Rong Chen Tilney, Lauren Zichittella, Grace M. Lee, Alison Tse Kawai
Related Assessments	Influenza Vaccines and Febrile Seizures in the 2013-2014 and 2014-2015 Influenza Seasons
Publication Type	Publication

Search form